Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,496 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,773
Recruiting: 1,496
Ph III recruiting: 183
Growth YoY: +7.3%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,526)

clinicaltrialsPublishedShowing 751–752 of 752 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00254319	Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)	unknown	Phase 2	—	The Cooper Health SystemOTHER	1	Nov 16, 2005	clinicaltrials
NCT00238849	Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.	unknown	Phase 2	40	Integrated Community Oncology NetworkOTHER	1	Oct 14, 2005	clinicaltrials